Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
LQDA Liquidia Technologies	$14.18 -2.2%	$14.92	$8.26 ▼ $19.41	$1.21B	-0.01	1.31 million shs	1.16 million shs
PLSE Pulse Biosciences	$15.69 +3.1%	$16.28	$13.50 ▼ $25.00	$1.06B	1.56	175,500 shs	97,102 shs
SMTI Sanara MedTech	$27.99 +2.8%	$29.72	$25.86 ▼ $39.08	$248.78M	1.3	32,135 shs	60,212 shs
SSII SS Innovations International	$6.74 +26.5%	$6.33	$0.32 ▼ $22.42	$1.30B	N/A	128,117 shs	360,054 shs

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
LQDA Liquidia Technologies	+0.21%	+13.54%	+2.91%	+6.07%	+16.64%
PLSE Pulse Biosciences	-5.29%	-2.00%	-3.49%	-9.89%	-21.99%
SMTI Sanara MedTech	-5.68%	-10.13%	-5.48%	-5.09%	-8.19%
SSII SS Innovations International	+12.21%	+10.81%	+50.56%	+532,999,900.00%	+532,999,900.00%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
LQDA Liquidia Technologies	3.1421 of 5 stars	4.5	0.0	0.0	0.0	1.5	4.2	0.6
PLSE Pulse Biosciences	3.8588 of 5 stars	3.5	0.0	0.0	4.2	1.9	4.2	0.0
SMTI Sanara MedTech	2.357 of 5 stars	3.5	1.0	0.0	0.0	3.3	1.7	0.6
SSII SS Innovations International	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
LQDA Liquidia Technologies	3.00	Buy	$26.89	89.57% Upside
PLSE Pulse Biosciences	3.00	Buy	$22.00	40.23% Upside
SMTI Sanara MedTech	3.00	Buy	$49.50	76.85% Upside
SSII SS Innovations International	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest SMTI, LQDA, SSII, and PLSE Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/7/2025	PLSE Pulse Biosciences	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$22.00
6/12/2025	LQDA Liquidia Technologies	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$23.00 ➝ $25.00
6/11/2025	LQDA Liquidia Technologies	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$25.00 ➝ $23.00
6/2/2025	LQDA Liquidia Technologies	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
5/28/2025	LQDA Liquidia Technologies	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Sector Outperform ➝ Sector Outperform	$36.00 ➝ $37.00
5/28/2025	LQDA Liquidia Technologies	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$20.00 ➝ $23.00
5/28/2025	LQDA Liquidia Technologies	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$25.00
5/28/2025	LQDA Liquidia Technologies	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$29.00 ➝ $35.00
5/27/2025	LQDA Liquidia Technologies	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
5/21/2025	LQDA Liquidia Technologies	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$25.00 ➝ $25.00
5/19/2025	LQDA Liquidia Technologies	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Market Perform ➝ Underperform	$13.00

(Data available from 7/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
LQDA Liquidia Technologies	$14.14M	85.73	N/A	N/A	$0.91 per share	15.59
PLSE Pulse Biosciences	$700K	1,507.71	N/A	N/A	$1.87 per share	8.39
SMTI Sanara MedTech	$91.57M	2.72	N/A	N/A	$4.45 per share	6.29
SSII SS Innovations International	$20.65M	63.19	N/A	N/A	$0.08 per share	84.25

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
LQDA Liquidia Technologies	-$130.39M	-$1.58	N/A	N/A	N/A	-903.80%	-177.91%	-60.15%	8/6/2025 (Estimated)
PLSE Pulse Biosciences	-$53.58M	N/A	0.00	∞	N/A	N/A	-68.44%	-58.17%	8/14/2025 (Estimated)
SMTI Sanara MedTech	-$9.66M	-$1.34	N/A	N/A	N/A	-12.48%	-29.22%	-13.20%	8/11/2025 (Estimated)
SSII SS Innovations International	-$19.15M	N/A	0.00	∞	N/A	-67.73%	-70.64%	-32.95%	N/A

Latest SMTI, LQDA, SSII, and PLSE Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/11/2025	Q2 2025	SMTI Sanara MedTech	-$0.33	N/A	N/A	N/A	$25.15 million	N/A
8/6/2025	Q2 2025	LQDA Liquidia Technologies	-$0.43	N/A	N/A	N/A	$3.90 million	N/A
5/14/2025	Q1 2025	SMTI Sanara MedTech	-$0.31	-$0.41	-$0.10	-$0.41	$23.48 million	$23.43 million
5/8/2025	Q1 2025	LQDA Liquidia Technologies	-$0.42	-$0.45	-$0.03	-$0.45	$3.23 million	$3.12 million
5/8/2025	Q1 2025	PLSE Pulse Biosciences	N/A	-$0.25	N/A	-$0.25	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
LQDA Liquidia Technologies	N/A	N/A	N/A	N/A	N/A
PLSE Pulse Biosciences	N/A	N/A	N/A	N/A	N/A
SMTI Sanara MedTech	N/A	N/A	N/A	N/A	N/A
SSII SS Innovations International	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
LQDA Liquidia Technologies	2.08	2.93	2.91
PLSE Pulse Biosciences	N/A	15.58	15.58
SMTI Sanara MedTech	1.18	2.77	2.54
SSII SS Innovations International	N/A	3.18	2.22

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
LQDA Liquidia Technologies	64.54%
PLSE Pulse Biosciences	76.95%
SMTI Sanara MedTech	8.10%
SSII SS Innovations International	N/A

Insider Ownership

Company	Insider Ownership
LQDA Liquidia Technologies	30.10%
PLSE Pulse Biosciences	71.50%
SMTI Sanara MedTech	42.60%
SSII SS Innovations International	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
LQDA Liquidia Technologies	50	85.49 million	59.75 million	Optionable
PLSE Pulse Biosciences	140	67.27 million	19.17 million	Optionable
SMTI Sanara MedTech	60	8.89 million	5.10 million	Not Optionable
SSII SS Innovations International	4	193.60 million	N/A	N/A

SMTI, LQDA, SSII, and PLSE Headlines

Recent News About These Companies

SS Innovations International (NASDAQ:SSII) Shares Up 7.1% - Still a Buy?

4 hours ago | marketbeat.com

SS Innovations International (NASDAQ:SSII) Shares Gap Up - Here's What Happened

July 15 at 1:48 PM | marketbeat.com

SS Innovations Surpasses Milestone of 100 Installations of the SSi Mantra Surgical Robotic System

July 15 at 8:47 AM | prismmediawire.comP

SS Innovations International (NASDAQ:SSII) Shares Gap Down - Time to Sell?

July 11, 2025 | marketbeat.com

SS Innovations International (NASDAQ:SSII) Shares Up 13.7% - Here's What Happened

July 10, 2025 | marketbeat.com

SS Innovations Announces Completion of World's First Robotic Telesurgery for Weight Loss with the Company's SSi Mantra 3 Surgical Robotic System

July 10, 2025 | prismmediawire.comP

SS Innovations Announces Completion of World's First Robotic Telesurgery for Weight Loss with the Company's SSi Mantra 3 Surgical Robotic System

July 10, 2025 | globenewswire.com

SS Innovations International (NASDAQ:SSII) Trading Down 8.7% - Should You Sell?

July 8, 2025 | marketbeat.com

SS Innovations International (NASDAQ:SSII) Trading Up 6.4% - Here's Why

July 3, 2025 | marketbeat.com

SS Innovations International (NASDAQ:SSII) Trading Down 5.5% - Here's What Happened

July 2, 2025 | marketbeat.com

SS Innovations International (NASDAQ:SSII) Stock Price Down 4.1% - What's Next?

June 26, 2025 | marketbeat.com

SS Innovations International (NASDAQ:SSII) Shares Up 8.1% - What's Next?

June 24, 2025 | marketbeat.com

SS Innovations International (NASDAQ:SSII) Shares Gap Down - Here's Why

June 23, 2025 | marketbeat.com

SS Innovations International (NASDAQ:SSII) Sees Large Volume Increase - Here's What Happened

June 20, 2025 | marketbeat.com

SS Innovations International (NASDAQ:SSII) Stock Price Up 10.8% - Time to Buy?

June 20, 2025 | marketbeat.com

SS Innovations: A Speculative Bet On Robotic Surgeries

June 19, 2025 | seekingalpha.com

SS Innovations Announces Successful Completion of First Robotic Cardiac Surgery in the Western Hemisphere Utilizing the Company's SSi Mantra 3 Surgical Robotic System

June 16, 2025 | prismmediawire.comP

SS Innovations Announces Successful Completion of First Robotic Cardiac Surgery in the Western Hemisphere Utilizing the Company's SSi Mantra 3 Surgical Robotic System

June 16, 2025 | globenewswire.com

SS Innovations Surpasses Milestone of 4,000 Robotic Surgeries Successfully Performed with the SSi Mantra Surgical Robotic System

May 27, 2025 | prismmediawire.comP

SS Innovations Surpasses Milestone of 4,000 Robotic Surgeries Successfully Performed with the SSi Mantra Surgical Robotic System

May 27, 2025 | globenewswire.com

SS Innovations Reports First Quarter 2025 Financial Results

May 14, 2025 | prismmediawire.comP

New MarketBeat Followers Over Time

Media Sentiment Over Time

SMTI, LQDA, SSII, and PLSE Company Descriptions

Liquidia Technologies NASDAQ:LQDA

$14.18 -0.33 (-2.25%)

Closing price 03:59 PM Eastern

Extended Trading

$14.18 +0.00 (+0.01%)

As of 04:01 PM Eastern

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneous infusion. The company also a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.

Pulse Biosciences NASDAQ:PLSE

$15.69 +0.47 (+3.08%)

Closing price 03:59 PM Eastern

Extended Trading

$15.72 +0.03 (+0.17%)

As of 04:01 PM Eastern

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.

Sanara MedTech NASDAQ:SMTI

$27.99 +0.76 (+2.79%)

Closing price 03:59 PM Eastern

Extended Trading

$27.99 0.00 (0.00%)

As of 04:01 PM Eastern

Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns; and HYCOL, a medical hydrolysate of Type I bovine collagen intended for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. It also provides BIAKOS Antimicrobial Skin and Wound Cleanser, a patented product that contains synergistic ingredients that have been shown to impact mature biofilm microbes; BIAKOS Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing that helps against planktonic microbes, as well as immature and mature biofilms; and BIAKOS Antimicrobial Skin and Wound Irrigation Solution. In addition, it develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement; and VIM Amnion Matrix, a homologous wound covering product. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.

SS Innovations International NASDAQ:SSII

$6.74 +1.41 (+26.45%)

As of 03:45 PM Eastern

AVRA Medical Robotics, Inc. develops and manufactures medical surgical devices. The company has a research agreement with the University of Central Florida to develop navigation and control technologies with applications in medical robotics. The company was formerly known as AVRA Surgical Microsystems, Inc. and changed its name to AVRA Medical Robotics, Inc. in November 2015. AVRA Medical Robotics, Inc. was founded in 2015 and is based in Orlando, Florida.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time